ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Rheumatoid arthritis (RA)"

  • Abstract Number: 2282 • 2019 ACR/ARP Annual Meeting

    Reproductive Counseling Documentation Practices for Women Receiving Teratogenic Medications in an Academic Rheumatology Clinic Serving a Medicaid/Medicare Patient Population

    Kimberly Showalter1, Melanie Smith 2, Jonathan Cheah 2, Nilasha Ghosh 2, Elena Gkrouzman 2, Sarah Lieber 2, Sebastian Sattui 2, Noa Schwartz 2, Monica Schwartzman 2, Jessica Berman 2, Lisa Sammaritano 2 and Anne Bass 3, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, 3Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

    Background/Purpose: Women of reproductive age with rheumatic diseases are often prescribed teratogenic medications; thus, reproductive counseling is important. A prior study demonstrated improvement in counseling…
  • Abstract Number: 2320 • 2019 ACR/ARP Annual Meeting

    Knowledge of Cardiovascular Disease Risk Among Patients with Rheumatoid Arthritis

    Juan Bande1, María Medina 1, Julia Sosa 1, María Kohan 1, Silvia Papasidero 1, José Caracciolo 1, Diana Klajn 1, Julio Wacker 1, Analía Alvarez 2, Romina Lim 2, Eduardo Kerzberg 3, Damaris Alvarez 3, Alejandra Trampuz 3, Gustavo Citera 4, Maria Correa 5, Analia Dellepiane 6, Adriana Perez Davila 7, Analía Verónica Bohr 7, Dora Pereira 8, Federico Giordano 8, Mónica Sacnun 9, Claudia Hartvig, 9, Maria Noelia Bersano 9, Mónica Díaz 10, Vanesa Cecilia Cruzat 11, Laura Raiti 12, Julia Demarchi 13, Iván Dario Remolina Rincón 13, Carolina Segura Escobar 13, Mariana Benegas 14, Etel Saturansky 14, Emma Civit 15, Federica Garignani 15, Gustavo Casado 16, Andrea M. Smichowski 16, Noel Agustin Callahuara Goiburu 17, Juan Arguello 17, Maria Paula Girard Bosch 18, Rosana Quintana 19, Bernardo A. Pons-Estel 19, Carla Gobbi 20, Darío Scublinsky 21, Mariana Salcedo 22, Maria de la Vega 23, Eliana Blanco 24, Hernán Maldonado Ficco 25, Lucía Degioanni 25, Nicolás Perez 26, Alejandro Martinez Muñoz 27 Silvina Mariana Rodriguez 28, Karin Kirmayr 29 and Sandra Petruzzelli30, 1Hospital General de Agudos Dr. E. Tornú, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 2Hospital General de Agudos José M. Penna, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 3Hospital Ramos Mejía, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 4Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 5Consultorios Reumatológicos Pampa, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 6CEMEC, Casilda, Santa Fe, Argentina, 7Hospital de Rehabilitación M. Rocca, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 8Hospital Zonal de Agudos Dr. Ricardo Gutiérrez, La Plata, Buenos Aires, Argentina, 9Hospital Provincial de Rosario, Rosario, Santa Fe, Argentina, 10Centro Traumatológico Bariloche, San Carlos de Bariloche, Rio Negro, Argentina, 11Clínica Bessone, Buenos Aires, Argentina, 12Clinica Bessone, Buenos Aires, Argentina, 13Hospital Británico, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 14Sanatorio Mendez, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 15OSEP. Universidad de Mendoza. F.C. Médicas, Ciudad de Mendoza, Argentina, 16Hospital Militar Central, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 17Hospital General de Agudos B. Rivadavia, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 18Instituto Médico Platense, La Plata, Argentina, 19Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Rosario, Argentina, 20CÁTEDRA DE CLÍNICA MÉDICA I, HOSPITAL CÓRDOBA, FACULTAD DE CIENCIAS MÉDICAS, UNIVERSIDAD NACIONAL DE CÓRDOBA, ARGENTINA, Cordoba, Argentina, 21Centros Médicos Ambulatorios SMG, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 22Instituto de Cardiología, San Nicolás, Santa Fe, Argentina, 23CEIM Investigaciones Medicas, Buenos Aires, Argentina, 24Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 25Hospital San Antonio de Padua, Río Cuarto, Cordoba, Argentina, 26Instituto de Investigaciones Médicas Alfredo Lanari, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 27Hospital Municipal Dr. R. Larcade, San Miguel, Buenos Aires, Argentina, 28Hospital Municipal de Trauma y Emergencias Dr. Federico Abete, Malvinas Argentinas, Buenos Aires, Argentina, 29Hospital Zonal Bariloche, Bariloche, Argentina, 30Casa Hospital San Juan de Dios, La Plata, Buenos Aires, Argentina

    Background/Purpose: Patients with rheumatoid arthritis (RA) have a significantly higher risk of cardiovascular disease (CVD) than general population. The Heart Disease Fact Questionnaire (HDFQ-RA 1…
  • Abstract Number: 2339 • 2019 ACR/ARP Annual Meeting

    Exposure to Avian and Fungal Antigens in Patients with Rheumatoid Arthritis-AssociatedInterstitial Lung Disease: Something to Keep in Mind

    Sebastian Rodriguez-Garcia1, Raul Castellanos-Moreira 2, Fernanda Hernández-González 3, Albert Perez 4, Joel Francesqui 5, Sandra Cuerpo-Cardeñosa 5, Virginia Ruiz-Esquide 6, Mariana Benegas 7, José Ramírez 8, Carmen Lucena-Pozo 3, Carlos Agustí 3, Marc Boada 9, Estíbaliz Ruiz 4, Odette Viñas 4, Sergio Prieto-González 10, Raimon Sanmarti 11, Gerard Espinosa 12, Mariona Pascal 13, Jose Gomez-Puerta 11, Marcelo Sánchez 7 and Jacobo Sellares 3, 1Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Spain, 2Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 3Department of Pneumology, Hospital Clínic, Barcelona, Barcelona, Spain, 4Department of Immunology, Hospital Clínic, Barcelona, Barcelona, Spain, 5Pneumology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 6Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 7Department of Radiodiagnosis, Hospital Clínic, Barcelona, Barcelona, Spain, 8Department of Pathological Anatomy, Hospital Clínic, Barcelona, Barcelona, Spain, 9Department of Thoracic Surgery, Hospital Clínic, Barcelona, Barcelona, Spain, 10Department of Systemic Autoimmune Diseases Hospital Clínic, Barcelona, Barcelona, Spain, 11Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain, 12Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 13Immunology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain

    Background/Purpose: Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is an extra-articular manifestation with a poor prognosis. In clinical practice, to establish such a diagnosis requires…
  • Abstract Number: 2364 • 2019 ACR/ARP Annual Meeting

    Multi-center Analyses on 518 Cases with Rheumatoid Arthritis Developing Lymphoproliferative Disorders (RA-LPD): The Prognostic Factors and the Influence of Anti-rheumatic Drugs on LPD Development

    Yoshihiko Hoshida1, Shiro Ohshima 2, Yukihiko Saeki 3, Masao Katayama 4, Tomoya Miyamura 5, Atsuahi Hashimoto 6, Shinji Higa 7, Hisaji Oshima 8, Masato Yagita 9, Yasushi Hiramatsu 10, Norie Yoshikawa 11, Akiko Mitsuo 12, Akira Okamoto 13, Noriyuki Chiba 14, Takao Sugiyama 15, Shouhei Nagaoka 16, Shoji Sugii 17, Keigo Setoguchi 18, Asami Abe 19, Toshiaki Sugaya 20, Masahiro Koseto 21, Yasuo Kunugiza 22, Ryousuke Yoshihara 23, Shinichiro Tsunoda 24, Tomoaki Fujisaki 25, Hiroshi Furukawa 26, Kazuyoshi Saito 27, Kiyoshi Matsui 28, Yasuhiko Tomita 29 and Shigeto Tohma 30, 1National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan, 2NHO Osaka Minami Medical Canter, Kawachinagano, Osaka, Japan, 3NHO Osaka Minami Medical Center, Kawachinagano, Osaka, Japan, 4National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 5NHO Kyusyu Medical Center, Fukuoka, Japan, 6NHO Sagamihara Hospital, Sagamihara, Japan, 7Osaka Second Police Hospital, Osaka, Japan, 8NHO Tokyo Medical Hospital, Tokyo, Japan, 9Kitano Hospital, Osaka, Japan, 10Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo, Japan, 11NHO Miyakonojo Medical Center, Miyakonojo, Miyazaki, Japan, 12NHO Disaster Medical Center, Tokyo, Tokyo, Japan, 13National Hospital Organization HImeji Medical Center, Himeji, Hyogo, Japan, 14National Hospital Organization Morioka Medical Center, Morioka, Iwate, Japan, 15NHO Shimoshizu Hospital, Chiba, Chiba, Japan, 16Yokohama Minami Kyousai Hospital, Yokohama, Kanagawa, Japan, 17Department of Rheumatic Diseases, Tokyo Metropoitan Tama Medica Center, Fuchu, Japan, 18Tokyo Metropolitan Cancer and Infectious Dease Center Komagome Hospital, Tokyo, Tokyo, Japan, 19Niigata Rheumatic Center, Shibata, Niigata, Japan, 20Fuchu Hospital, Izumi, Osaka, Japan, 21Nippon Life Hospital, Osaka, Osaka, Japan, 22JCHO Hoshigaoka Medical Center, Katano, Osaka, Japan, 23Hyogo Prefecture Kakogawa Hospital, Kakogawa, Hyogo, Japan, 24Sumitomo Hospital, osaka, Osaka, Japan, 25Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan, 26Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 27University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan, 28Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, 29International University of health and welfare, Narita, Chiba, Japan, 30National Hospital Organization Tokyo National Hospital, Tokyo, Japan

    Background/Purpose: Lymphoproliferative disorders (LPD) remains as a major problem to resolve among the patients with rheumatoid arthritis (RA). During few decades, rheumatic therapy has dramatically…
  • Abstract Number: 2390 • 2019 ACR/ARP Annual Meeting

    Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission

    Melanie Hagen1, Koray Tascilar 2, Michaela Reiser 3, Judith Haschka 4, Arnd Kleyer 5, Larissa Valor 6, Bernhard Manger 7, Georg Schett 8 and Jürgen Rech 9, 1Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Bayern, Germany, 3Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 4Karl Landsteiner Institute for Gastroenterology and Rheumatology, St. Vincent Hospital Vienna, II Medical Department, Vienna, Austria, 5Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany, 6Friedrich-Alexander-University Erlangen-Nürnberg. Department of Internal Medicine 3 - Rheumatology and Immunology. Erlangen., Erlangen, Germany, 7Friedrich-Alexander-University Erlangen-Nürnberg. Department of Internal Medicine 3 - Rheumatology and Immunology. Erlangen. Germany., Erlangen, Germany, 8Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 9Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Achieving remission is the ultimate treatment goal in patients with rheumatoid arthritis (RA). With the development and wider use of highly effective disease modifying…
  • Abstract Number: 2772 • 2019 ACR/ARP Annual Meeting

    Clinical and Biological Changes in Rheumatoid Arthritis Patients Exposed to an Anti-inflammatory Diet

    francesca cedola1, Roxana Coras 2, Marta Fernandez-Bustamante 3, Meritxell Agusti-Perez 3, Maram Al-Harthi 3, Susan Lee 3, Abha Singh 3, Choi Soo 3, Kathy Nguyen 3, Oswald Quehenberger 3, Tatyana Shekhtman 3, Shahrokh Golshan 3 and Monica Guma 4, 1University of California San Diego, Rome, Italy, 2. Department of Medicine, School of Medicine. University of California, San Diego, 3University of California San Diego, san diego, 4Department of Medicine, School of Medicine. University of California San Diego, La Jolla, United States

    Background/Purpose: RA patients often inquire about dietary interventions to improve disease control, as they perceive quick changes in pain and/or swelling after consumption of certain…
  • Abstract Number: 2872 • 2019 ACR/ARP Annual Meeting

    Risk of 30-day Readmission and Adverse Events After Primary Hip or Knee Arthroplasty: A Comparison of Patients with Rheumatoid Arthritis versus Osteoarthritis Using the Nationwide Readmission Database

    Ali Yazdanyar1, Anthony Donato 2, Kathleen McElwee 3, Mary Chester Wasko 4 and Michael Ward 5, 1Lehigh Valley Hospital- Cedar Crest, Allentown, PA, 2Reading Hospital, PA, Reading, 3Reading Hospital, Reading, PA, 4Allegheny Health Network-West Penn Hospital, Pittsburgh, PA, 5NIAMS, Bethesda, MD

    Background/Purpose: To assess the risk of 30-day readmission, mortality, and adverse events among adults with Rheumatoid Arthritis as compared to Osteoarthritis after primary hip or…
  • Abstract Number: 34 • 2019 ACR/ARP Annual Meeting

    The Role of NFAT5-p65 Complex Enhanceosome in the Inflammatory Responses of Rheumatoid Arthritis Synovial Fibroblasts via TLR4 Signaling

    Kunihiko Umekita1, Yumi Kariya 1, Chihiro Iwao 1, Masatoshi Kimura 1, Risa Kudo 1, Yuki Rikitake 1, Shunichi Miyauchi 2 and Akihiko Okayama 1, 1University of Miyazaki, Miyazaki, Japan, 2University of Miyazaki, Miyazaki

    Background/Purpose: Transcription factors belonging to the family of nuclear factors of activated T cells (NFAT) play an essential role in diverse biological processes, such as…
  • Abstract Number: 116 • 2019 ACR/ARP Annual Meeting

    Defective EZH2 Expression Attenuates Treg Differentiation in Rheumatoid Arthritis

    Xinyue Xiao1, Yueting Li 2, Hua Chen 1 and Xuan Zhang 2, 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, Beijing, China, Beijing, Beijing, China (People's Republic), 2Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College; The Ministry of Education Key Laboratory, Beijing, China, Beijing, China (People's Republic)

    Background/Purpose: To explore the role of EZH2, a histone methylation regulator, in the pathogenesis of rheumatoid arthritis (RA).Methods: Forty treatment-naïve patients with active disease and…
  • Abstract Number: 195 • 2019 ACR/ARP Annual Meeting

    The Clinical Characteristics of Patients with Inflammatory Arthritis and a Persistently Low Alkaline Phosphatase Level in a Veteran Affairs Rheumatology Clinic

    Luke Monteagudo1, Amy Gravely 2, Peter Valen 3 and David Ewart 3, 1The University of Minnesota, Minneapolis, 2Minneapolis Veteran Affairs Medical Center, Minneapolis, 3University of Minnesota School of Medicine/ Minneapolis Veteran Affairs Medical Center, Minneapolis

    Background/Purpose: Background: The biochemical hallmark of hypophosphatasia (HPP) is a low alkaline phosphatase (ALP) level. It is recognized that some forms of HPP present in adulthood…
  • Abstract Number: 300 • 2019 ACR/ARP Annual Meeting

    Proliferative Globular Synovitis, an Ultrasound Pattern Associated with Seropositive Rheumatoid Arthritis

    Ana Belén Azuaga-Piñango1, Beatriz Frade-Sosa 2, Roberto Gumucio 3, Katherine Cajiao-Sanchez 2, Stanislava Mandelikova 2, Virginia Ruiz-Esquide 4, Raul Castellanos-Moreira 2, Raimon Sanmarti 5, Juan Cañete 5 and Julio Ramirez 1, 1Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 2Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain, 3Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 4Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 5Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain

    Background/Purpose: Rheumatoid Arthritis (RA) has a synovial ultrasound (US) pattern, while soft tissue involvement is more frequently found in Psoriatic Arthritis (PsA). No previous studies…
  • Abstract Number: 453 • 2019 ACR/ARP Annual Meeting

    Including Pain, Fatigue and Functionality Regularly in the Assessment of Patients with Early Rheumatoid Arthritis Separately Adds to the Evaluation of Disease Status

    Sofia Pazmino1, Anikó Lovik 2, Annelies Boonen 3, Diederik De Cock 1, Veerle Stouten 1, Johan Joly 4, Kristien Van der Elst 5, Delphine Bertrand 1, Rene Westhovens 6 and Patrick Verschueren 5, 1KU Leuven, Leuven, Belgium, 2Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Vlaams-Brabant, Belgium, 3Maastricht University Medical Center, Maastricht, Netherlands, 4University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium, 5University Hospital Leuven, Leuven, Belgium, 6University Hospitals, Leuven, Belgium

    Background/Purpose: Rheumatoid arthritis (RA) level of disease activity, cannot be evaluated by a single clinical or laboratory measurement. Hence, composite indices have been created via…
  • Abstract Number: 478 • 2019 ACR/ARP Annual Meeting

    The Influence of Gender on Composite Disease Activity Indices for Rheumatoid Arthritis

    Takahiro NIshino1, Atsushi Hasimoto 1, Shigeto Tohma 2 and Toshihiro Matsui 1, 1National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan, 2National Hospital Organization Tokyo National Hospital, Tokyo, Japan

    Background/Purpose: Disease activity of patients with rheumatoid arthritis should be assessed equally independent of gender, age, or disease duration. However, at present, they are not…
  • Abstract Number: 531 • 2019 ACR/ARP Annual Meeting

    Efficacy and Safety of Gonadotropin-Releasing Hormone Antagonism in Severe Biologic Refractory Rheumatoid Arthritis

    Anita Kass1, Hans Christian Gulseth 1 and Camilla Zettel 1, 1Betanien Hospital, Skien, Norway

    Background/Purpose: The pathogenesis of rheumatoid arthritis (RA) is unclear, and additional therapeutic approaches are needed. The improvement of RA disease activity during pregnancy, and flares during the…
  • Abstract Number: 839 • 2019 ACR/ARP Annual Meeting

    Disease Activity, Cytokine Profiles, and the Risk of Incident Diabetes in Rheumatoid Arthritis

    Joshua Baker1, Bryant England 2, Michael George 3, Grant Cannon 4 and Ted Mikuls 5, 1University of Pennsylvania, Philadelphia, PA, 2VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, 3University of Pennsylvania, Philadelphia, 4Salt Lake City VA Medical Center and Univeristy of Utah, Salt Lake City, UT, 5VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis is associated with a higher risk of diabetes mellitus (DM) and cardiovascular disease. While disproportional obesity and visceral fat accumulation may contribute…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 56
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology